Skip to main content
. 2020 Aug 30;9(2):363–376. doi: 10.1007/s40119-020-00199-y

Fig. 2.

Fig. 2

Schema representing the development of myocardial fibrosis and sites of action of potential therapeutic targets. RAAS renin–angiotensin–aldosterone system, TGFβ tissue growth factor-β, TNFα tumour necrosis factor-α, CTGF connective tissue growth factor, IL-11 interleukin-11, miRNA microRNA, MMP matrix metalloproteinases, Gal-3 galectin-3